Dividend Power Score
A single, comprehensive score designed to measure the true strength of a company’s dividend.
This score combines three essential pillars of dividend quality:
Consistency – Measures how reliable the dividend has been over time, focusing on payment history, stability, and the absence of cuts or suspensions.
Payability – Assesses the company’s financial ability to sustain its dividend, taking into account cash flow, earnings coverage, balance sheet strength, and overall financial health.
Growth – Evaluates the long-term growth of both the dividend and the company’s share price, highlighting businesses that consistently increase payouts while creating shareholder value.
Higher scores identify companies that have historically delivered dependable income alongside sustained dividend growth and long-term capital appreciation.
Company Overview
Vaso Corporation (NASDAQ: VASO) is a diversified healthcare and medical technology company focused primarily on healthcare information technology (IT), professional sales services, and diagnostic imaging equipment. The company operates in the broader healthcare services and medical technology industries, with revenue generated through managed network and infrastructure services, healthcare software support, sales representation activities, and medical device distribution. Vaso’s business model combines recurring service-based healthcare IT revenue with commission-based sales activities tied to medical imaging and healthcare products.
The company’s primary operating businesses include VasoTechnology, which delivers healthcare IT and managed services; Professional Sales Service (PSS) operations, which provide outsourced sales representation for medical equipment manufacturers; and medical equipment activities involving imaging products and related technology solutions. Vaso has historically positioned itself as a niche provider serving hospitals, physician groups, healthcare systems, and medical device manufacturers. Originally founded as a medical device company associated with vascular diagnostic technology, the company evolved through acquisitions and restructuring into a diversified healthcare services enterprise with increased emphasis on IT infrastructure and healthcare network management.
Business Operations
Vaso generates revenue through three principal business areas: IT segment operations, Professional Sales Service (PSS) activities, and medical equipment sales and support. Through VasoTechnology, including subsidiaries such as NetWolves, the company provides managed network services, cloud infrastructure support, cybersecurity, healthcare connectivity, and data center solutions. These services are delivered to healthcare providers as well as commercial and government customers, creating recurring contractual revenue streams. The PSS business operates through long-term sales representation agreements with healthcare equipment manufacturers, supporting product promotion and sales execution across the United States.
The company’s operations are primarily concentrated in the United States, although its IT and network services support customers with broader geographic requirements. Vaso controls technology infrastructure and managed service capabilities through NetWolves, which functions as a key strategic operating subsidiary. Historically, the company also participated in medical imaging distribution and service activities involving diagnostic equipment. Revenue generation is diversified between recurring managed services contracts, commissions earned through sales representation agreements, and equipment-related activities. Public filings and company disclosures indicate that healthcare IT services have become increasingly central to the company’s operational strategy.
Strategic Position & Investments
Vaso’s strategic direction has emphasized expansion in healthcare IT infrastructure, managed cybersecurity services, and recurring technology-based revenue models. The company has invested in strengthening its managed network operations through NetWolves, positioning itself to benefit from increased healthcare digitization, cybersecurity demand, and cloud-based healthcare infrastructure requirements. Management has repeatedly highlighted the importance of long-term service contracts and operational scalability within its IT business as a core growth objective.
The company’s historical acquisition activity includes the integration of NetWolves, which materially expanded Vaso’s technology capabilities and diversified its revenue beyond traditional medical device operations. Vaso has also maintained strategic relationships through its sales representation segment, allowing participation in diagnostic imaging and healthcare equipment markets without directly manufacturing large-scale medical hardware. Public disclosures indicate continuing focus on healthcare-related technology services, secure communications infrastructure, and enterprise managed services. Data regarding major international investment activity outside the United States remains limited in publicly available filings.
Geographic Footprint
Vaso is headquartered in Plainview, New York, and conducts the majority of its business activities within the United States. Its healthcare IT and professional sales operations support customers nationwide, including healthcare providers, hospital systems, medical equipment companies, and enterprise clients requiring network and infrastructure management services. The company’s sales representation activities operate across multiple regional healthcare markets in North America.
Through NetWolves, Vaso maintains technology infrastructure and managed service capabilities that can support geographically distributed clients, including customers with international networking requirements. However, publicly available information indicates that the company’s direct operational footprint remains predominantly U.S.-focused rather than globally expansive. The company’s influence outside North America appears primarily connected to service capabilities rather than large-scale foreign subsidiaries or manufacturing operations.
Leadership & Governance
Vaso’s leadership team oversees a diversified healthcare technology and services platform focused on operational efficiency, recurring service revenue, and healthcare infrastructure modernization. Corporate governance and strategic priorities are communicated through annual reports, earnings disclosures, and regulatory filings, particularly in SEC filings including Forms 10-K and 10-Q. Leadership has consistently emphasized disciplined growth in managed IT services alongside maintaining long-term customer and partner relationships within the healthcare sector.
Key executives and leadership figures include:
- Jun Ma – Chief Executive Officer
- William “Bill” Zima – Chief Financial Officer
- Dr. Clifford M. Gross – Chairman of the Board
- Mark Newbauer – Executive leadership role within NetWolves operations
Publicly available information indicates that management strategy prioritizes expansion of technology-enabled healthcare services, operational integration across subsidiaries, and development of stable recurring revenue streams through managed service contracts and healthcare-related IT solutions.